RecruitingNCT05504681

Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic

Sponsor

Baptist Health South Florida

Enrollment

200 participants

Start Date

Nov 30, 2021

Study Type

OBSERVATIONAL

Conditions

Neurocognitive Disorders

Summary

This is prospective observational registry study that will assess 1) if the neurocognitive function app (Brainlab Cognition) can be used in a widespread neuro-oncology clinic setting and 2) if patient reported quality of life parameters can be obtained electronically and integrated into clinic.

Eligibility

Min Age: 18 Years

Inclusion Criteria3

All adult (18+) patients with central nervous system (CNS) tumors, both primary brain malignancies and brain metastases, treated with radiotherapy (partial brain, stereotactic radiosurgery, stereotactic fractionated radiotherapy, or whole-brain radiotherapy), surgery, and/or antineoplastic therapy and followed thereafter at Miami Cancer Institute (MCI)
Life expectancy ≥ 6 months
Willingness to participate in ongoing registration study

Exclusion Criteria2

Patients receiving radiotherapy to the brain for functional disease (arteriovenous malformations, trigeminal neuralgia, essential tremors, etc.)
Pediatric patients (<18 years old), pregnant women, and prisoners.

Interested in this trial?

Get notified about updates and connect with the research team.